A High-Throughput,Homogeneous Microplate Assay for Agents That Kill Mammalian Tissue Culture Cells

Abstract

Screens for cytostasis/cytoxicity have considerable value for the discovery of therapeutic agents and the investigation of the biology of apoptosis. For instance, genetic screens for proteins, protein fragments, peptides, RNAs, or chemicals that kill tissue culture cells may aid in identifying new cancer therapeutic targets. A microplate assay for cell death is needed to achieve throughputs sufficient to sift through thousands of agents from expression or chemical libraries. The authors describe a homogeneous assay for cell death in tissue culture cells compatible with 96- or 384-well plates. In combination with a previously described system for retroviral packaging and transduction, nearly 6000 expression library clones could be screened per week in a 96-well plate format. The screening system may also prove useful for chemical screens. (Journal of Biomolecular Screening 2003:283-291)

References

1. Maines JZ: Positive selection of growth-inhibitory genes . Cell Growth Differ 1995;6: 665-671 .

2. Pestov DG, Grzeszkiewica TM, Lau LF: Isolation of growth suppressors from a cDNA library . Oncogene 1998;17: 3187-3197 .

3. Grimm S, Leder P: An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes . J Exp Med 1997;185: 1137-1142 .

4. Bauer MK, Schubert A, Rocks O, Grimm S: Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis . J Cell Biol 1999;147: 1493-1502 .

5. Simons AH, Dafni N, Dotan I, Oron Y, Canaani D: Genetic synthetic lethality screen at the single gene level in cultured human cells . Nucleic Acids Res 2001;29: e100-e100 .

6. Stump M, Di Sera L, Rebentisch M, Endo M, Pierce M, Kamb A: An automated system for screening retroviral expression constructs in microplate format . J Biomol Screen 2002;7(3): 275-280 .

7. Sandrock RW, Peterson I, Evans C, Wheatley W, Kamb A: Enhanced expression of exogenous genes from retroviruses using HIV2/Tat . J Biotechnol 2002;97: 41-50 .

8. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ: BID: a novel BH3 domain-only death agonist . Genes Dev 1996;10: 2859-2869 .

9. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, et al: Functional interaction of beta-catenin with the transcription factor LEF-1 . Nature 1996;382: 638-642 .

10.

10. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma . Science 1997;275: 1784-1787 .

11.

11. Sadot E, Simcha I, Shtutman M, Ben-Ze'ev A, Geiger B: Inhibition of beta-catenin-mediated transactivation by cadherin derivatives . Proc Natl Acad Sci USA 1998;95: 15339-15344 .

12.

12. Wheatley W, Pierce M, Rebentisch M, Endo M, Peterson I, Stump M, Kamb A: Genetic selection for modulators of the MAP kinase and b-catenin growth-control pathways in mammalian cells . Biochem Gen 2002;40(11-12): 359-378 .